GHRS GH Research PLC
Price (delayed)
$10.4
Market cap
$541.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.75
Enterprise value
$440.93M
gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.
Highlights
GH Research's debt has decreased by 36% YoY and by 15% QoQ
The quick ratio fell by 31% YoY but it rose by 9% QoQ
GHRS's EPS is down by 10% year-on-year but it is up by 5% since the previous quarter
GH Research's equity has decreased by 18% YoY and by 5% QoQ
Key stats
What are the main financial stats of GHRS
Market
Valuations
Earnings
Shares outstanding
52.03M
Market cap
$541.09M
Enterprise value
$440.93M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.02
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$50.31M
Net income
-$38.96M
EBIT
-$38.24M
EBITDA
-$37.93M
Free cash flow
-$48.69M
Per share
Balance sheet
Liquidity
EPS
-$0.75
EPS diluted
-$0.75
Free cash flow per share
-$0.94
Book value per share
$3.44
Revenue per share
$0
TBVPS
$3.62
Total assets
$188.27M
Total liabilities
$9.32M
Debt
$624,000
Equity
$178.95M
Working capital
$145.27M
Debt to equity
0
Current ratio
17.23
Quick ratio
16.68
Net debt/EBITDA
2.64
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-19.2%
Return on equity
-20.1%
Return on invested capital
-35.9%
Return on capital employed
-21.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GHRS stock price
How has the GH Research stock price performed over time
Intraday
-3.35%
1 week
-13.76%
1 month
2.67%
1 year
-5.8%
YTD
48.57%
QTD
-5.71%
Financial performance
How have GH Research's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$50.31M
Net income
-$38.96M
Gross margin
N/A
Net margin
N/A
GH Research's operating income has decreased by 22% YoY and by 3.7% from the previous quarter
GH Research's net income has decreased by 9% YoY but it has increased by 6% from the previous quarter
Growth
What is GH Research's growth rate over time
Valuation
What is GH Research stock price valuation
P/E
N/A
P/B
3.02
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GHRS's EPS is down by 10% year-on-year but it is up by 5% since the previous quarter
The price to book (P/B) is 30% more than the last 4 quarters average of 2.4
GH Research's equity has decreased by 18% YoY and by 5% QoQ
Efficiency
How efficient is GH Research business performance
GHRS's return on invested capital is down by 44% year-on-year and by 8% since the previous quarter
GHRS's return on equity is down by 30% year-on-year
The return on assets has declined by 28% year-on-year
Dividends
What is GHRS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GHRS.
Financial health
How did GH Research financials performed over time
The quick ratio fell by 31% YoY but it rose by 9% QoQ
GHRS's current ratio is down by 30% year-on-year but it is up by 9% since the previous quarter
GH Research's debt is 100% lower than its equity
GH Research's debt has decreased by 36% YoY and by 15% QoQ
GH Research's equity has decreased by 18% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.